The altered ENOSF1/TYMS ratio could also be the underlying basis of the severe hand-foot syndrome that is observed in a subset of cancer-affected individuals treated with 5-fluorouracil and related cancer drugs. The gene discussed is ENOSF1; the disease is cancer.